Fundraising Fox

Genomedx Biosciences

San Diego, US · Founded 2018 · Delaware corporation

Healthtech

Founders & leadership

Genomedx Biosciences was founded in 2018 by Elai Davicioni.

ED
Elai DavicioniFounder
WK
William KachioffExecutive
DD
Doug DolginowExecutive
EH
Edwin HendrickinExecutive
TT
Timothy TricheNamed on SEC filing

Board

CJ
Craig JohnsonBoard director
GR
George RehmBoard director
ML
Michael LiangBoard director
DR
Daniel R. OmsteadBoard director
LS
Lawrence SenourBoard director
TS
Tina S. NovaBoard director

Reported raises · per SEC filings

Form D private placements

$72.9M disclosed across 9 rounds · 2016–2020

▶$8MraisedMay 2020 · 35 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES W. TRUESSDirector
  • JOHN ABALLIExecutive Officer
  • KATHY HIBBSDirector
  • TODD HOLMESDirector
  • BASHAR DABBASExecutive Officer
  • HENRY SKINNERDirector
  • ROBERT EPSTEINDirector
  • TINA S. NOVAExecutive Officer, Director
  • RYAN DITTAMOREExecutive Officer
  • BRENT VETTERExecutive Officer
  • ELAI DAVICIONIExecutive Officer
Offering amount
$18.1M
Amount sold
$8M
First sale
May 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13MraisedApr 2019 · 37 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • BASHAR DABBASExecutive Officer
  • ANDREW LEVITCHDirector
  • FRANK MUHLENBECKDirector
  • HENRY SKINNERDirector
  • TINA NOVAExecutive Officer, Director
  • TODD HOLMESDirector
  • BRENT VETTERExecutive Officer
  • ADAM CHINNOCKExecutive Officer
  • JOHN ABALLIExecutive Officer
  • ELAI DAVICIONIExecutive Officer
Offering amount
$25.6M
Amount sold
$13M
First sale
Mar 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.2MraisedJan 2019 · 37 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • HENRY SKINNERDirector
  • BRENT VETTERExecutive Officer
  • TINA NOVAExecutive Officer, Director
  • JOHN ABALLIExecutive Officer
  • ANDREW LEVITCHDirector
  • ELAI DAVICIONIExecutive Officer
  • FRANK MUHLENBECKDirector
  • ADAM CHINNOCKExecutive Officer
  • TODD HOLMESDirector
Offering amount
$3.2M
Amount sold
$3.2M
First sale
Dec 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.4MraisedOct 2018 · 36 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • TODD HOLMESDirector
  • ANDREW LEVITCHDirector
  • JOHN ABALLIExecutive Officer
  • TINA NOVAExecutive Officer, Director
  • ADAM CHINNOCKExecutive Officer
  • HENRY SKINNERDirector
  • BRENT VETTERExecutive Officer
  • FRANK MUHLENBECKDirector
  • ELAI DAVICIONIExecutive Officer
Offering amount
$7M
Amount sold
$3.4M
First sale
Oct 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.7MraisedSep 2018 · 41 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • LAWRENCE SENOURDirector
  • TODD HOLMESDirector
  • TINA NOVAExecutive Officer, Director
  • HENRY SKINNERDirector
  • ADAM CHINNOCKExecutive Officer
  • ELAI DAVICIONIExecutive Officer
  • JOHN ABALLIExecutive Officer
  • FRANK MUHLENBECKDirector
  • BRENT VETTERExecutive Officer
Offering amount
$3M
Amount sold
$2.7M
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.1MraisedApr 2018 · 29 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael LiangDirector
  • Daniel R. OmsteadDirector
  • Timothy TricheDirector
  • Adam ChinnockExecutive Officer
  • Elai DavicioniExecutive Officer, Director
  • Edwin HendrickExecutive Officer
  • Craig JohnsonDirector
  • Lawrence SenourDirector
  • George RehmDirector
  • Michael RodriguezExecutive Officer
  • Tina S. NovaDirector
Offering amount
$16M
Amount sold
$6.1M
First sale
Apr 2018
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.9MraisedNov 2017 · 30 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Adam ChinnockExecutive Officer
  • Craig JohnsonDirector
  • Tina S. NovaDirector
  • Timothy TricheDirector
  • George RehmDirector
  • Michael LiangDirector
  • Edwin HendrickExecutive Officer
  • Lawrence SenourDirector
  • Daniel R. OmsteadDirector
  • Doug DolginowExecutive Officer, Director
  • Michael RodriguezExecutive Officer
  • Elai DavicioniExecutive Officer, Director
Offering amount
$10M
Amount sold
$4.9M
First sale
Nov 2017
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.3MraisedJun 2017 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel R. OmsteadDirector
  • Craig JohnsonDirector
  • Timothy TricheDirector
  • Adam ChinnockExecutive Officer
  • Michael LiangDirector
  • Tina S. NovaDirector
  • Elai DavicioniExecutive Officer, Director
  • Edwin HendrickExecutive Officer
  • Doug DolginowExecutive Officer, Director
  • George RehmDirector
  • Lawrence SenourDirector
  • Michael RodriguezExecutive Officer
Offering amount
$21M
Amount sold
$6.3M
First sale
Jun 2017
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Genomedx Biosciences?
Genomedx Biosciences was founded by Elai Davicioni in 2018.
How much funding has Genomedx Biosciences raised?
Genomedx Biosciences has disclosed $72.9M raised across 9 rounds.
Where is Genomedx Biosciences headquartered?
Genomedx Biosciences is headquartered in San Diego, US.